EPS Creative Health Technology Group Limited provided unaudited consolidated earnings guidance for the year ended 31 March 2024. For the period, the group expects to record a loss of approximately HKD 30 million, as compared to a loss of approximately HKD 50 million for the same period last year. The expected reduction in loss was mainly attributable to the revenue generated from healthcare products business for the Year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.83 HKD | +6.41% | +10.67% | -7.78% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.78% | 55.52M | |
-21.63% | 666M | |
-0.58% | 336M | |
+125.48% | 267M | |
-53.41% | 178M | |
+222.92% | 162M | |
+21.14% | 144M | |
0.00% | 136M | |
+46.81% | 98.46M | |
-48.90% | 91.41M |
- Stock Market
- Equities
- 3860 Stock
- News EPS Creative Health Technology Group Limited
- EPS Creative Health Technology Group Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 March 2024